Genmab
Genmab is a biotechnology company focused on the development of innovative antibody-based therapies for cancer and other diseases. The company aims to improve patient outcomes through cutting-edge research and development in the biotech sector.
Industries
biotechnology
health-care
manufacturing
medical
Nr. of Employees
large (251-1000)
Genmab
Products
Proprietary antibody platform technologies
A set of antibody engineering platforms enabling bispecific antibody generation, Fc-region modulation and enhanced complement activation to create optimized therapeutic candidates.
Proprietary antibody platform technologies
A set of antibody engineering platforms enabling bispecific antibody generation, Fc-region modulation and enhanced complement activation to create optimized therapeutic candidates.
Services
Collaborative discovery and co-development partnerships
Partnership-based discovery, preclinical development and co-development of antibody therapeutics with external biopharma organizations.
Collaborative discovery and co-development partnerships
Partnership-based discovery, preclinical development and co-development of antibody therapeutics with external biopharma organizations.
Expertise Areas
- Antibody therapeutics development
- Bispecific antibody engineering
- Fc engineering and effector-function optimization
- Preclinical pharmacology and biomarker development
Key Technologies
- Monoclonal antibody discovery
- Bispecific antibody platforms (Fab-arm exchange)
- Fc-region engineering
- Antibody hexamerization for complement activation